Understanding Infantile Hemangioma
April 29, 2015
“You No Longer Have To Watch and Wait.”
Awareness of Infantile Hemangioma
What could be more frightening than bringing your newborn baby home in perfect health, then noticing a bright red tumor-like growth on your baby’s skin? What’s more frustrating than seeking multiple medical opinions, only to be told “just watch and wait”? Infantile Hemangioma is a common benign growth that affects millions of newborn babies. A small percentage can be dangerous to a child’s health, and many more can leave permanent tissue damage if untreated. Until recently, awareness of Infantile Hemangioma was minimal, and available treatments carried significant side effects. A truly groundbreaking treatment has changed the landscape of Pediatric Dermatology. Leading experts like Dr. Ana Duarte, Founder of the Children’s Skin Center and Head of Dermatology at Miami Children’s Hospital, have called this drug “a true game-changer”. Watch and see how it is changing the lives of families living with Infantile Hemangioma.
Walkasins® is a newly available external lower limb sensory prosthesis designed to replace lost nerve function in patients with peripheral neuropathy.
The EB Research Partnership is the largest global organization dedicated to funding research to treat and cure Epidermolysis Bullosa or EB.
Laithwaites is a wine subscription that exclusively selects a range of small-batch, handcrafted wines from top-quality family estates and passionate winemakers from every corner of the world.